This Working Paper is available here as an Adobe Acrobat PDF. 

Abstract

Part I of this AEI Working Paper looks at the history of Vioxx and asks questions about potential over-deterrence from having manufacturers bear the full measure of the social cost of drugs through strict products liability or failure-to-warn claims.

Ted Frank is a resident fellow at AEI.